Category: C.R. Bard
A federal appeals court declines to re-hear a January ruling that added more than $200 million to W.L. Gore & Assoc.'s $854 million tab in their stent graft patent war.
A federal appeals court upholds C.R. Bard's win in a product liability lawsuit filed over its G2 inferior vena cava filter.
Ferolyn Powell, the former CEO of Evalve who led it to a $410 million acquisition by Abbott, is killed in a motorbike accident in Thailand.
Former Evalve CEO Ferolyn Powell, who led the MitraClip developer to a $410 million acquisition by Abbott (NYSE:ABT), died this month in a motorbike accident in northern Thailand, her family said yesterday.
, Cantel Medical Corp.
, Clayton Dubilier Rice
, InVivo Therapeutics Corp.
, JP Morgan Chase
, NxThera Inc.
, Spectranetics Corp.
, SurModics Inc.
, Urologix Inc.
, Abbott Laboratories
Here's a look at some of the top legal news stories for medical device companies this week: Ex-sales rep sues Medtronic, claims she was fired for blowing the whistle; J&J's Ethicon settles Prolift pelvic mesh bellwether; Appeals court upholds AngioDynamics injunction, $160m penalty against Biolitec; Bard's Medafor wins injunction against CryoLife's PerClot Topical
A federal judge grants C.R. Bard's Medafor division's bid for an injunction barring U.S. sales of CryoLife's PerClot Topical hemostasis powder.
C. R. Bard is reportedly close to settling a suit filed in a West Virginia federal court by a woman who claimed she was injured by the company's pelvic-mesh device, Avaulta Plus.
C.R. Bard (NYSE:BCR) is reportedly close to settling a suit filed in West Virginia federal court by a woman who claimed she was injured by the company's pelvic-mesh device, Avaulta Plus.
C.R. Bard inks a deal for Boston Scientific to distribute its Lutonix drug-eluting balloon in the U.S.